Nurse Practitioner · Rochester, MN
NPI
1841305240
Since 2006
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
200 1st St SW
Rochester, MN, 55905
Phone (507) 284-2511
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
363 services
Medicare patients, 2024
164
Average age 77
Drug cost, 2024
$7.7M
1,538 prescriptions
Company payments, 2024
$1,375
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Janell G Frantz was code 99215 (office e&m - established), 108 times for 87 patients. In total Janell G Frantz billed 363 services in 10 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 108 | 87 | $122.33 | $13K |
| 99214 Office E&M - Established | Office | 85 | 59 | $86.23 | $7,330 |
| 99213 Office E&M - Established | Office | 50 | 35 | $58.32 | $2,916 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 44 | 24 | $11.25 | $495 |
| 99442 Telephone Services | Office | 30 | 25 | $60.29 | $1,809 |
| 99443 Telephone Services | Office | 27 | 25 | $80.47 | $2,173 |
By year: 2022 $30K for 366 services; 2023 $25K for 322 services; 2024 $29K for 363 services.
Medicare prescription drug claims, 2024
In 2024, the drug Janell G Frantz prescribed most often to Medicare patients was Vyndamax (Tafamidis), with 217 prescriptions and refills. In total Janell G Frantz wrote 1,538 Medicare prescriptions that cost $7.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vyndamax Tafamidis | 217 | 223 | 29 | $5.0M |
| Metoprolol Succinate Generic | 141 | 384 | 46 | $4,617 |
| Spironolactone Generic | 124 | 320 | 35 | $1,138 |
| Torsemide Generic | 119 | 313 | 47 | $3,967 |
| Vyndaqel Tafamidis Meglumine | 104 | 108 | 15 | $2.4M |
| Entresto Sacubitril/Valsartan | 94 | 192 | 27 | $127K |
| Carvedilol Generic | 79 | 217 | 23 | $811 |
| Eliquis Apixaban | 76 | 186 | 23 | $104K |
| Potassium Chloride Generic | 70 | 146 | 24 | $2,251 |
| Losartan Potassium Generic | 70 | 188 | 17 | $600 |
| Lisinopril Generic | 65 | 189 | 20 | $571 |
| Jardiance Empagliflozin | 51 | 87 | 11 | $50K |
| Atorvastatin Calcium Generic | 37 | 105 | 16 | $469 |
| Furosemide Generic | 30 | 67 | 13 | $208 |
| Farxiga Dapagliflozin Propanediol | 24 | 54 | Under 11 | $28K |
Brand drugs: 597 claims; generic drugs: 941 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Janell G Frantz $1,375 ($1,375 in general payments such as food, travel and fees) from 1 company. The largest payer was Biotronik Inc. with $1,375.
| Company | Payments | Amount |
|---|---|---|
| Biotronik Inc. | 7 | $1,375 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.